Celularity Inc. Class A Common Stock

CELUNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
0.78 USD
↗ 0.01 (1.59%)AT CLOSE (11:59 AM EDT)
0.80
↗ 0.01 (1.88%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
0.80
↗ 0.01 (1.88%)
🔴Market: CLOSED

CELU is currently priced at $0.78. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (241.3%) and a bearish Death Cross on the long-term moving averages. On the valuation side, CELU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 17, 2026.

Open?$0.76
High?$0.84
Low?$0.75
Prev. Close?$0.77
Volume?16.9K
Avg. Volume?142.6K
VWAP?$0.80
Rel. Volume?0.12x
Bid / Ask
Bid?$0.76 × 1.1K
Ask?$0.77 × 400
Spread?$0.01
Midpoint?$0.77
Valuation & Ratios
Market Cap?22.6M
Shares Out?28.9M
Float?7.3M
Float %?25.1%
P/E Ratio?N/A
P/B Ratio?-0.59
EPS?-$3.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Clinical-Stage Platforms
Employees
115
Market Cap
22.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.celularity.com
Listed
2021-07-19
Address
170 PARK AVE
FLORHAM PARK, NJ 07932
Phone: (908) 768-2170
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
10
Short Sent.?
44
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.24Distress
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.69%Elevated
Short Interest?413.4K
Days to Cover?3.3
Free Float7.3M
Avg Daily Volume124.5K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.15Weak
Quick Ratio?0.15Weak
Cash Ratio?0.08Low
Debt/Equity?-1.26Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.59CHEAP▾
P/S?
Peers
100
S&P
89
0.85CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
Peers
100
S&P
69
2.42CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
241.3%STRONG▾
ROA?
S&P
3
-85.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$64.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist